17
GLP-1 may slow biological aging (www.universityofcalifornia.edu)
submitted 3 weeks ago by [B] to c/hackernews@lemmy.bestiver.se
5 comments fedilink hide all child comments
 

Comments

you are viewing a single comment's thread
view the rest of the comments
[–] 7 points 3 weeks ago (2 children)

May also means may not

We can rewrite the title as

Glp1s may not slow biological aging

  • permalink
  • fedilink
  • source
  • hideshow 2 child comments
    •
  • [–] 3 points 3 weeks ago (1 child)

    However, the study found compared to the placebo group:

    • Participants treated with semaglutide exhibited a broad pattern of slower biological aging across epigenetic clocks linked to inflammation and blood, brain, heart, kidney, liver and metabolic health.

    • The drug slowed the pace of biological aging by 9 %, as measured by the DunedinPACE epigenetic clock.

    • The drug significantly slowed biological processes associated with the risk of all‑cause mortality and age-related disease, as measured by the PCGrimAgeepigenetic clock.

    It's just that the study focused on people with a particular condition so it takes more studies to know if it affects the general population similarly.

  • permalink
  • fedilink
  • source
  • parent
  • hideshow 1 child comment
    •
  • [–] 3 points 3 weeks ago

    are these unique to the glp-1 intervention or are they echos of ketone production, fat metabolism, increased insulin sensitivity... are there more effective ways to achieve the same marker improvements without using a glp-1? (obviously yes)

    Making casual claims like slow biological aging requires the context which the data is based, and a demonstration of the mechanisms.

  • permalink
  • fedilink
  • source
  • parent